Glenview Capital Management 13F Portfolio Q3 2025

Glenview Capital Management, LLC (CIK: 0001138995) is a financial institution headquartered at 767 Fifth Avenue, 44Th Floor, New York, New York 10153. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.

As of the latest reporting period (2025-09-30), the institution manages a portfolio valued at $4,492,312,861, comprising 54 distinct securities. Over its filing history, it has submitted 52 Form 13F reports.

To view the institution’s full SEC filing history:
🔗 View All SEC Filings

Top Buys

Q3 2025

1. TMO Thermo Fisher Scientific Inc.

+$88.73 M

2. Z Zillow Group, Inc.

+$68.55 M

3. GPN Global Payments Inc.

+$68.54 M

4. ICLR ICON Public Limited Company

+$65 M

5. DHR Danaher Corporation

+$42.51 M

Top Sells

Q3 2025

1. THC Tenet Healthcare Corporation

−$123.11 M

2. META Meta Platforms, Inc.

−$76.64 M

3. CI The Cigna Group

−$53.08 M

4. WDC Western Digital Corporation

−$38.43 M

5. EXPE Expedia Group, Inc.

−$31.73 M

Stocks/ETFs

+16.77%

$4.11 B 91.59%

Options

+727.11%

$377.52 M 8.40%

Debt

$0 0.00%

Other

-24.38%

$78,128 0.00%

Name	Shares	Market Value	Weight	Change	Activity
CVS Health Corporation CVS	8,196,799	$617,956,677	13.76%
Tenet Healthcare Corporation THC	2,323,679	$471,799,784	10.50%	▼ 606,326	Reduce -20.7%
Global Payments Inc. GPN	5,141,892	$427,188,387	9.51%	▲ 825,000	Add 19.1%
Teva Pharmaceutical Industries Limited TEVA	16,692,680	$337,192,136	7.51%	▲ 868,457	Add 5.5%
ZoomInfo Technologies Inc. GTM	18,505,242	$201,892,190	4.49%	▲ 2,123,843	Add 13.0%
Amazon.com, Inc. AMZN	652,138	$143,189,941	3.19%	▲ 89,264	Add 15.9%
Thermo Fisher Scientific Inc. TMO	282,941	$137,232,044	3.05%	▲ 182,941	Add 182.9%
DXC Technology Company DXC	8,339,897	$113,672,796	2.53%	▲ 2,473,350	Add 42.2%
Universal Health Services, Inc. UHS	482,169	$98,574,630	2.19%	▲ 92,692	Add 23.8%
PayPal Holdings, Inc. PYPL	1,333,370	$89,415,792	1.99%	▲ 327,226	Add 32.5%

View Full List

Glenview Capital Management, LLC's Portfolio

This portfolio view aggregates one or more SEC Form 13F filings submitted by Glenview Capital Management, LLC each quarter. Holdings are organized into Stocks/ETFs, Options, Debt, and Other, with transaction markers indicating New Buy, Add, Reduce, No Change, or Sold Out. Reported anomalies are corrected where possible, and share counts are adjusted to reflect corporate actions such as stock splits. Since 2013, we have collected 50 quarters of portfolio data for this firm, providing a transparent record of institutional strategy over time.

Stocks ETFs

Name	Shares	Value	% of Portfolio	% Change
Loading holdings data...

Showing 1-20 of 0 records

Show: per page

Note: Shares, Shares Change - split-adjusted.

CALL PUT

Type	Name	Shares	Value	% of Portfolio	% Change
Loading options data...

Showing 1-20 of 0 records

Show: per page

Note: Shares, Shares Change - split-adjusted.

Name	Amount	Value	% of Portfolio	% Change
Loading debt data...

Showing 1-20 of 0 records

Show: per page

Note: Shares, Shares Change - split-adjusted.

Name	Shares	Value	% of Portfolio	% Change
Loading other data...

Showing 1-20 of 0 records

Show: per page

Note: Shares, Shares Change - split-adjusted.

Glenview Capital Management, LLC Quarterly 13F Statistics

📊 Discover detailed insights into Glenview Capital Management, LLC’s SEC Form 13F filings, including:

Quarterly changes in holdings
Portfolio turnover
Asset allocation trends
Top 10 stock and ETF positions

This page provides a transparent view of institutional strategies based on official SEC disclosures, helping investors track long‑term shifts since 2013.

Quarter	Holdings	Total Value	Turnover Rate	Asset Allocation	Top 10 Stock & ETF Holdings

Showing 1-20 of 0 records

Show: per page

Glenview Capital Management, LLC's All 13F Filings

📑 This section lists all SEC Form 13F filings submitted by Glenview Capital Management, LLC, a registered institutional investment manager. Since 2013, we have tracked a total of 0 filings submitted by this firm.

Form 13F must be filed within 45 days after the end of each calendar quarter and discloses the reporting manager, the securities held, their CUSIP numbers, the number of shares held at quarter-end, and the total reported market value.

Please note that the market value shown reflects reported holdings only and should not be considered a substitute for Assets Under Management (AUM), as cash positions are excluded.
Each filing entry includes a direct link to the original Form 13F document on the SEC’s EDGAR system .

Report For	Filed At	AUM	Holdings	Form Type	Source

Showing 1-20 of 0 records

Show: per page

Glenview Capital Management, LLC 13F Filings, Portfolio & Analysis

Glenview Capital Management, LLC — Portfolio Overview & Company Profile

Portfolio Summary (Q3 2025)

Top Buys

Top Sells

Asset Allocation

Sector Allocation (Stocks)

Top Stock & ETF Holdings (Q3 2025)

Historical Portfolio Charts

Glenview Capital Management, LLC's Portfolio

Glenview Capital Management, LLC Quarterly 13F Statistics

Glenview Capital Management, LLC's All 13F Filings